FDA Inspection
Watson Pharmaceuticals IncWatson Pharmaceuticals Inc – FDA Inspection, Sep 27, 2011
Record Details
This FDA Inspection record concerns Watson Pharmaceuticals Inc, with an inspection on September 27, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Watson Pharmaceuticals Inc
- Inspection Date
- September 27, 2011
- Product Type
- Drugs
View Company Profile
ID · a793403b-bab2-4d53-bcc7-49de46f795f1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 747130
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 314.80(c)(1)(ii)Submission of report follow-up
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(c)(2)Late submission of annual safety reports
- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Watson Pharmaceuticals Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Watson Pharmaceuticals Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.